Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Phenylbutyrate rescues the transport defect of the Sec61α mutations V67G and T185A for renin

M. Sicking, M. Živná, P. Bhadra, V. Barešová, A. Tirincsi, D. Hadzibeganovic, K. Hodaňová, P. Vyleťal, J. Sovová, I. Jedličková, M. Jung, T. Bell, V. Helms, AJ. Bleyer, S. Kmoch, A. Cavalié, S. Lang

. 2022 ; 5 (4) : . [pub] 20220121

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22011281

The human Sec61 complex is a widely distributed and abundant molecular machine. It resides in the membrane of the endoplasmic reticulum to channel two types of cargo: protein substrates and calcium ions. The SEC61A1 gene encodes for the pore-forming Sec61α subunit of the Sec61 complex. Despite their ubiquitous expression, the idiopathic SEC61A1 missense mutations p.V67G and p.T185A trigger a localized disease pattern diagnosed as autosomal dominant tubulointerstitial kidney disease (ADTKD-SEC61A1). Using cellular disease models for ADTKD-SEC61A1, we identified an impaired protein transport of the renal secretory protein renin and a reduced abundance of regulatory calcium transporters, including SERCA2. Treatment with the molecular chaperone phenylbutyrate reversed the defective protein transport of renin and the imbalanced calcium homeostasis. Signal peptide substitution experiments pointed at targeting sequences as the cause for the substrate-specific impairment of protein transport in the presence of the V67G or T185A mutations. Similarly, dominant mutations in the signal peptide of renin also cause ADTKD and point to impaired transport of this renal hormone as important pathogenic feature for ADTKD-SEC61A1 patients as well.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22011281
003      
CZ-PrNML
005      
20220506131458.0
007      
ta
008      
220425s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.26508/lsa.202101150 $2 doi
035    __
$a (PubMed)35064074
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Sicking, Mark $u Department of Medical Biochemistry and Molecular Biology, Saarland University, Homburg, Germany
245    10
$a Phenylbutyrate rescues the transport defect of the Sec61α mutations V67G and T185A for renin / $c M. Sicking, M. Živná, P. Bhadra, V. Barešová, A. Tirincsi, D. Hadzibeganovic, K. Hodaňová, P. Vyleťal, J. Sovová, I. Jedličková, M. Jung, T. Bell, V. Helms, AJ. Bleyer, S. Kmoch, A. Cavalié, S. Lang
520    9_
$a The human Sec61 complex is a widely distributed and abundant molecular machine. It resides in the membrane of the endoplasmic reticulum to channel two types of cargo: protein substrates and calcium ions. The SEC61A1 gene encodes for the pore-forming Sec61α subunit of the Sec61 complex. Despite their ubiquitous expression, the idiopathic SEC61A1 missense mutations p.V67G and p.T185A trigger a localized disease pattern diagnosed as autosomal dominant tubulointerstitial kidney disease (ADTKD-SEC61A1). Using cellular disease models for ADTKD-SEC61A1, we identified an impaired protein transport of the renal secretory protein renin and a reduced abundance of regulatory calcium transporters, including SERCA2. Treatment with the molecular chaperone phenylbutyrate reversed the defective protein transport of renin and the imbalanced calcium homeostasis. Signal peptide substitution experiments pointed at targeting sequences as the cause for the substrate-specific impairment of protein transport in the presence of the V67G or T185A mutations. Similarly, dominant mutations in the signal peptide of renin also cause ADTKD and point to impaired transport of this renal hormone as important pathogenic feature for ADTKD-SEC61A1 patients as well.
650    _2
$a vápník $x metabolismus $7 D002118
650    _2
$a endoplazmatické retikulum $x metabolismus $7 D004721
650    _2
$a HEK293 buňky $7 D057809
650    _2
$a lidé $7 D006801
650    _2
$a nemoci ledvin $x patofyziologie $7 D007674
650    _2
$a molekulární chaperony $x metabolismus $7 D018832
650    _2
$a missense mutace $7 D020125
650    _2
$a fenylbutyráty $x metabolismus $x farmakologie $7 D010654
650    _2
$a polycystická choroba ledvin $7 D007690
650    _2
$a transport proteinů $x genetika $7 D021381
650    _2
$a renin $x genetika $x metabolismus $7 D012083
650    _2
$a translokační kanály SEC $x chemie $x genetika $x metabolismus $7 D000069816
650    _2
$a sarkoplazmatická Ca2+-ATPáza $x metabolismus $7 D053498
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Živná, Martina $u Research Unit for Rare Diseases, Department of Pediatrics and Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Bhadra, Pratiti $u Center for Bioinformatics, Saarland University, Saarbrücken, Germany
700    1_
$a Barešová, Veronika $u Research Unit for Rare Diseases, Department of Pediatrics and Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Tirincsi, Andrea $u Department of Medical Biochemistry and Molecular Biology, Saarland University, Homburg, Germany $1 https://orcid.org/0000000208898340
700    1_
$a Hadzibeganovic, Drazena $u Department of Medical Biochemistry and Molecular Biology, Saarland University, Homburg, Germany
700    1_
$a Hodaňová, Kateřina $u Research Unit for Rare Diseases, Department of Pediatrics and Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Vyleťal, Petr $u Research Unit for Rare Diseases, Department of Pediatrics and Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Sovová, Jana $u Research Unit for Rare Diseases, Department of Pediatrics and Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Jedličková, Ivana $u Research Unit for Rare Diseases, Department of Pediatrics and Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Jung, Martin $u Department of Medical Biochemistry and Molecular Biology, Saarland University, Homburg, Germany $1 https://orcid.org/0000000214827020
700    1_
$a Bell, Thomas $u Department of Chemistry, University of Nevada, Reno, NV, USA
700    1_
$a Helms, Volkhard $u Center for Bioinformatics, Saarland University, Saarbrücken, Germany $1 https://orcid.org/0000000221809154
700    1_
$a Bleyer, Anthony J $u Research Unit for Rare Diseases, Department of Pediatrics and Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic $u Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, NC, USA
700    1_
$a Kmoch, Stanislav $u Research Unit for Rare Diseases, Department of Pediatrics and Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Cavalié, Adolfo $u Experimental and Clinical Pharmacology and Toxicology, Pre-clinical Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany
700    1_
$a Lang, Sven $u Department of Medical Biochemistry and Molecular Biology, Saarland University, Homburg, Germany sven.lang@uni-saarland.de $1 https://orcid.org/0000000313261851
773    0_
$w MED00197314 $t Life science alliance $x 2575-1077 $g Roč. 5, č. 4 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35064074 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506131450 $b ABA008
999    __
$a ok $b bmc $g 1789065 $s 1162479
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 5 $c 4 $e 20220121 $i 2575-1077 $m Life science alliance $n Life sci. alliance $x MED00197314
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...